cmp semaglutide/cyan 2.5mg/0.5mg/ml inj Ozempic 2 mg/1.5 mL (1.34 mg/mL) prefilled pen that delivers 0.25 mg or 0.5 mg per injection Images Semaglutide Injection 2.5 mg 0.5mg/ml

Describe the characteristics and epidemiology of the main VBDs in the European region

The key mechanisms include: Appetite suppression: Semaglutide acts on hypothalamic centers in the brain to reduce hunger and increase satiety Delayed gastric emptying: Food moves through the stomach more slowly, prolonging the feeling of fullness Improved insulin sensitivity: Better glucose regulation reduces insulin-driven fat storage Reduced food reward signaling: Semaglutide appears to decrease the neurological reward response to food In the STEP 1 clinical trial, participants receiving semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks compared to 2.4% with placebo (Wilding et al., 2021, New England Journal of Medicine )

These advanced concepts aren't just academic

Consistent dosing is important for neurological recovery and blood health